Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
|
| gptkbp:activeIn |
Gram-positive bacteria
|
| gptkbp:administeredBy |
intravenous injection
|
| gptkbp:alternativeName |
gptkb:Daptomycin
|
| gptkbp:approvalYear |
2003
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:discoveredBy |
gptkb:Eli_Lilly_and_Company
|
| https://www.w3.org/2000/01/rdf-schema#label |
DZ-12
|
| gptkbp:marketedAs |
gptkb:Cubicin
|
| gptkbp:mechanismOfAction |
disrupts bacterial cell membrane
|
| gptkbp:usedFor |
treatment of bacterial infections
|
| gptkbp:bfsParent |
gptkb:Tebessa_Province
gptkb:Tébessa_Province |
| gptkbp:bfsLayer |
7
|